Published online February 1, 2008
PEDIATRICS Vol. 121 No. 2 February 2008, pp. 419-432 (doi:10.1542/10.1542/peds.2007-3283)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engle, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engle, W. A.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CLINICAL REPORT

Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate

William A. Engle, MD and the Committee on Fetus and Newborn

Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia/sepsis, and perhaps pulmonary hemorrhage; surfactant replacement may be beneficial for these infants. This statement summarizes indications, administration, formulations, and outcomes for surfactant-replacement therapy. The impact of antenatal steroids and continuous positive airway pressure on outcomes and surfactant use in preterm infants is reviewed. Because respiratory insufficiency may be a component of multiorgan dysfunction, preterm and term infants receiving surfactant-replacement therapy should be managed in facilities with technical and clinical expertise to administer surfactant and provide multisystem support.


Key Words: surfactant • antenatal steroids • respiratory distress syndrome • meconium aspiration syndrome • neonatal pneumonia • neonatal sepsis • congenital diaphragmatic hernia • pulmonary hemorrhage • persistent pulmonary hypertension • preterm • term

Abbreviations: RR—relative risk • CI—confidence interval • NNT—number needed to treat



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

The following policy statement has been revised:

Surfactant Replacement Therapy for Respiratory Distress Syndrome

Pediatrics 103: 684-685. [Full Text]



This article has been cited by other articles:


Home page
NeoReviewsHome page
J. B. Warren and J. M. Anderson
Core Concepts: Respiratory Distress Syndrome
NeoReviews, July 1, 2009; 10(7): e351 - e361.
[Abstract] [Full Text] [PDF]


Home page
EDUCATION AND PRACTICEHome page
D G Sweet and H L Halliday
The use of surfactants in 2009
Arch. Dis. Child. Ed. Pract., June 1, 2009; 94(3): 78 - 83.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
W. E. Truog
21st-Century Use for Surfactant?
Pediatrics, January 1, 2009; 123(1): 173 - 174.
[Full Text] [PDF]


Home page
Ther Adv Respir DisHome page
M. K. Lal and S. K. Sinha
Review: Surfactant respiratory therapy using Surfaxin/sinapultide
Therapeutic Advances in Respiratory Disease, October 1, 2008; 2(5): 339 - 344.
[Abstract] [PDF]


Home page
PediatricsHome page
F. Moya, S. Sinha, and R. B. D'Agostino Sr
Surfactant-Replacement Therapy for Respiratory Distress Syndrome in the Preterm and Term Neonate: Congratulations and Corrections
Pediatrics, June 1, 2008; 121(6): 1290 - 1291.
[Full Text] [PDF]


Home page
PediatricsHome page
W. A. Engle and A. R. Stark
Surfactant-Replacement Therapy for Respiratory Distress Syndrome in the Preterm and Term Neonate: Congratulations and Corrections: In Reply
Pediatrics, June 1, 2008; 121(6): 1291 - 1292.
[Full Text] [PDF]

eLetters:

Read all eLetters

Surfactant Prophylaxis in the Small but Stable Premature
Steve Piecuch, MD, MPH
Pediatrics Online, 15 Feb 2008 [Full text]